Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look ...

Researchers at Harvard Medical School developed a tool that could use artificial intelligence to accelerate drug discovery ...

These criteria ensure that the drug offers a genuine therapeutic difference, a requirement for its effectiveness against evolving AMR. Considering it can take 15 years and cost over $1 billion to ...

Ebrahimi is a scientific leader at GSK. Mrksich is the Henry Wade Rogers professor at Northwestern University, where he is developing the MegaMolecule technology for creating multifunctional ...

The wide range of chromatographic techniques share one common aim: to separate a material into its components. A material, your sample, is dissolved in a solvent, called the mobile phase. This mixture ...

The growing strength of China’s drug pipelines has gone hand-in-hand with a steep uptick in big pharma licensing deals.

Prescription drug prices in the US are roughly 2.78 times higher on average than in 33 other high-income countries, a 2024 ...

President Donald Trump and Pfizer's CEO today announced "TrumpRX" and lower drug prices. But what does Pfizer sell? Here's ...

Humanigen Inc has partnered with the U.S. government to help advance development of its drug candidate as a potential COVID-19 treatment following positive response in hospitalized patients in a ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that it’s “getting ready” to begin human clinical trials of drugs designed by AI. The news comes as tech ...